Oligonucleotide Immunotoxicity Case Study

Clinically Relevant Assessment of Therapeutic Oligo’s.

Discover how the ID.Flow® whole blood test system was used to assess the immunotoxicity of inotersen and imetelstat. This case study includes:

Detailed results and methodologies.
How to overcome the limitations of non-human primates in predicting human immune responses.
How to obtain clinically relevant immunotoxicity assessments of oligo’s.

.Whitepaper-module--form--11ad9.gbi-2040134972-kwAusiuXQtJkVjvF7F83E6:before { opacity: 1; background-image: linear-gradient(rgba(0, 0, 0, 0.37), rgba(0, 0, 0, 0.37)),url('/static/3a8f9910a128868f4669cbdb8b66f9e6/c8505/Non-human-primate.webp'); }

 Case Study
We're committed to your privacy. Immuneed uses the information you provide to us to contact you about our services. You may unsubscribe from these communications at any time. For more information, check out our privacy policy